Patterns of Sensitivity Exhibited By Venetoclax-Inclusive Drug Combinations in Acute Myeloid Leukemia

被引：1
作者：
Kurtz, Stephen E. [1 ,2 ]
Eide, Christopher A. [1 ]
Kaempf, Andy [3 ]
Long, Nicola [1 ]
Agarwal, Anupriya [1 ]
Tognon, Cristina E. [1 ]
Mori, Motomi [3 ]
Druker, Brian J. [1 ]
Tyner, Jeffrey W. [4 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Mail Code KR HEM, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Mail Code KR HEM, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Biostat Shared Resource, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-126020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
878
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Venetoclax-containing regimens in acute myeloid leukemia
    Aldoss, Ibrahim
    Pullarkat, Vinod
    Stein, Anthony S.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [42] Outpatient initiation of venetoclax in patients with acute myeloid leukemia
    Palmer, Shannon
    Patel, Anand
    Wang, Christopher
    Patel, Bianka
    Zeidner, Joshua
    Foster, Matthew
    Muluneh, Benyam
    Buhlinger, Kaitlyn
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (07) : 1590 - 1598
  • [43] Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia
    Emadi, Ashkan
    Kapadia, Bandish
    Bollino, Dominique
    Bhandary, Binny
    Baer, Maria R.
    Niyongere, Sandrine
    Strovel, Erin T.
    Kaizer, Hannah
    Chang, Elizabeth
    Choi, Eun Yong
    Ma, Xinrong
    Tighe, Kayla M.
    Carter-Cooper, Brandon
    Moses, Blake S.
    Civin, Curt I.
    Mahurkar, Anup
    Shetty, Amol C.
    Gartenhaus, Ronald B.
    Kamangar, Farin
    Lapidus, Rena G.
    LEUKEMIA, 2021, 35 (07) : 1907 - 1924
  • [44] Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia
    Saliba, Antoine N.
    John, August J.
    Kaufmann, Scott H.
    CANCER DRUG RESISTANCE, 2021, 4 (01) : 125 - 142
  • [45] Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
    Lima, Keli
    Vicari, Hugo Passos
    Elias Godoy Carlos, Jorge Antonio
    Lipreri da Silva, Jean Carlos
    de Figueiredo-Pontes, Lorena Lobo
    Rego, Eduardo Magalhaes
    Machado-Neto, Joao Agostinho
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2022, 44 (01) : 124 - 127
  • [46] Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia
    Ashkan Emadi
    Bandish Kapadia
    Dominique Bollino
    Binny Bhandary
    Maria R. Baer
    Sandrine Niyongere
    Erin T. Strovel
    Hannah Kaizer
    Elizabeth Chang
    Eun Yong Choi
    Xinrong Ma
    Kayla M. Tighe
    Brandon Carter-Cooper
    Blake S. Moses
    Curt I. Civin
    Anup Mahurkar
    Amol C. Shetty
    Ronald B. Gartenhaus
    Farin Kamangar
    Rena G. Lapidus
    Leukemia, 2021, 35 : 1907 - 1924
  • [47] Patterns of Relapse in Patients with Acute Myeloid Leukemia (AML) Treated with Venetoclax-Containing Regimens
    Arani, Naszrin
    Almanza, Emmanuel
    Bataller, Alex
    DiNardo, Courtney D.
    Ravandi, Farhad
    Daver, Naval
    Pemmaraju, Naveen
    Yilmaz, Musa
    Maiti, Abhishek
    Reville, Patrick K.
    Loghavi, Sanam
    Abbas, Hussein A.
    Garcia-Manero, Guillermo
    Short, Nicholas J.
    Kantarjian, Hagop M.
    Kadia, Tapan M.
    BLOOD, 2023, 142
  • [48] Patterns of Relapse Following Venetoclax-Based Therapies of Differing Intensity in Acute Myeloid Leukemia
    Arani, Naszrin
    Jen, Wei-Ping
    Bataller, Alex
    Bazinet, Alexandre
    Ravandi, Farhad
    Daver, Naval
    Takahashi, Koichi
    Loghavi, Sanam
    Abbas, Hussein A.
    Almanza, Emmanuel
    Montalban-Bravo, Guillermo
    Garcia-Manero, Guillermo
    Dinardo, Courtney D.
    Kantarjian, Hagop M.
    Kadia, Tapan M.
    BLOOD, 2024, 144 : 4293 - 4294
  • [49] The Growing Role of the BH3 Mimetic Drug Venetoclax in the Therapy of Acute Myeloid Leukemia
    Pelosi, Elvira
    Castelli, Germana
    Testa, Ugo
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2022, 14 : 1 - 23
  • [50] Potent Personalized Venetoclax Partners for Acute Myeloid Leukemia Identified by Ex Vivo Drug Screening
    Becker, Pamela S.
    BLOOD CANCER DISCOVERY, 2023, 4 (06): : 437 - 439
12345